Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan

Background: Immune checkpoint inhibitors (ICIs) have significantly changed the current approach to cancer treatment. Although the use of ICIs has become the standard of care for advanced melanoma, reports of ICI use among Asian populations with melanoma are limited. Therefore, we conducted this retr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chiao-En Wu, Chan-Keng Yang, Meng-Ting Peng, Pei-Wei Huang, Yu-Fen Lin, Chi-Yuan Cheng, Yao-Yu Chang, Huan-Wu Chen, Jia-Juan Hsieh, John Wen-Cheng Chang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-06-01
coleção:	Frontiers in Oncology
Assuntos:	melanoma immunotherapy nivolumab ipilimumab pembrolizumab immune checkpoint inhibitors
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fonc.2020.00905/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!